ArticleBMC cardiovascular disorders2024

Polyethylene glycol loxenatide protects diabetic kidneys by inhibiting GRP78/PERK/eIF2α pathway, and improves cardiac injury by suppressing TLR4/NF-κB inflammatory pathway.

Chen Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.